Unknown

Dataset Information

0

Identification of novel ?-secretase-associated proteins in detergent-resistant membranes from brain.


ABSTRACT: In Alzheimer disease, oligomeric amyloid ?-peptide (A?) species lead to synapse loss and neuronal death. ?-Secretase, the transmembrane protease complex that mediates the final catalytic step that liberates A? from its precursor protein (APP), has a multitude of substrates, and therapeutics aimed at reducing A? production should ideally be specific for APP cleavage. It has been shown that APP can be processed in lipid rafts, and ?-secretase-associated proteins can affect A? production. Here, we use a biotinylated inhibitor for affinity purification of ?-secretase and associated proteins and mass spectrometry for identification of the purified proteins, and we identify novel ?-secretase-associated proteins in detergent-resistant membranes from brain. Furthermore, we show by small interfering RNA-mediated knockdown of gene expression that a subset of the ?-secretase-associated proteins, in particular voltage-dependent anion channel 1 (VDAC1) and contactin-associated protein 1 (CNTNAP1), reduced A? production (A?40 and A?42) by around 70%, whereas knockdown of presenilin 1, one of the essential ?-secretase complex components, reduced A? production by 50%. Importantly, these proteins had a less pronounced effect on Notch processing. We conclude that VDAC1 and CNTNAP1 associate with ?-secretase in detergent-resistant membranes and affect APP processing and suggest that molecules that interfere with this interaction could be of therapeutic use for Alzheimer disease.

SUBMITTER: Hur JY 

PROVIDER: S-EPMC3320946 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.

Hur Ji-Yeun JY   Teranishi Yasuhiro Y   Kihara Takahiro T   Yamamoto Natsuko Goto NG   Inoue Mitsuhiro M   Hosia Waltteri W   Hashimoto Masakazu M   Winblad Bengt B   Frykman Susanne S   Tjernberg Lars O LO  

The Journal of biological chemistry 20120207 15


In Alzheimer disease, oligomeric amyloid β-peptide (Aβ) species lead to synapse loss and neuronal death. γ-Secretase, the transmembrane protease complex that mediates the final catalytic step that liberates Aβ from its precursor protein (APP), has a multitude of substrates, and therapeutics aimed at reducing Aβ production should ideally be specific for APP cleavage. It has been shown that APP can be processed in lipid rafts, and γ-secretase-associated proteins can affect Aβ production. Here, we  ...[more]

Similar Datasets

| S-EPMC6788730 | biostudies-literature
| S-EPMC2709549 | biostudies-literature
| S-EPMC3208356 | biostudies-literature
| S-EPMC2742443 | biostudies-literature
| S-EPMC4638043 | biostudies-literature
| S-EPMC6680987 | biostudies-literature
2017-03-28 | MSV000080708 | MassIVE
2021-11-03 | PXD028782 | Pride
2016-06-23 | PXD002554 | Pride
| S-EPMC4493071 | biostudies-literature